Effect of miR-196a2 rs11614913 Polymorphism on Cancer Susceptibility: Evidence From an Updated Meta-Analysis
- PMID: 35770306
- PMCID: PMC9251994
- DOI: 10.1177/15330338221109798
Effect of miR-196a2 rs11614913 Polymorphism on Cancer Susceptibility: Evidence From an Updated Meta-Analysis
Abstract
Background:MiR-196a2 rs11614913 polymorphism has been studied in a wide range of cancers throughout the years. Despite a large number of epidemiological studies performed in almost all ethnic populations, the contribution of this polymorphism to cancer risk is still inconclusive. Therefore, this updated meta-analysis was performed to estimate a meticulous correlation between miR-196a2 rs11614913 variant and cancer susceptibility. Methods: A systematic study search was carried out using PubMed, ScienceDirect, CNKI, EMBASE, Scopus, and Google Scholar databases following PRISMA guidelines to find necessary literature up to December 15, 2021. Pooled odds ratios with corresponding 95% confidence intervals were estimated using RevMan 5.4 based on ethnicities, cancer types, control sources, and genotyping methods. Results: A total of 152 studies, including 120 135 subjects (53 818 patients and 66 317 controls; 140 studies, after removing studies that deviated from HWE: 51 459 cases and 62 588 controls), were included in this meta-analysis. Quantitative synthesis suggests that the miR-196a2 rs11614913 genetic variant is significantly correlated with the reduced risk of overall cancer in CDM2, CDM3, RM, and AM (odds ratio < 1 and P < .05). It is also observed from ethnicity-based subgroup analysis that rs11614913 polymorphism is significantly (P < .05) linked with cancer in the Asian (in CDM2, CDM3, RM, AM) and the African population (in CDM1, CDM3, ODM). Stratified analysis based on the cancer types demonstrated a significantly decreased correlation for breast, hepatocellular, lung, and gynecological cancer and an increased association for oral and renal cell cancer. Again, the control population-based subgroup analysis reported a strongly reduced correlation for HB population in CDM2, RM, and AM. A substantially decreased risk was also observed for other genotyping methods in multiple genetic models. Conclusions:MiR-196a2 rs11614913 variant is significantly correlated with overall cancer susceptibility. Besides, rs11614913 is correlated with cancer in Asians and Africans. It is also correlated with breast, gynecological, hepatocellular, lung, oral, and renal cell cancer.
Keywords: MiR-196a2; cancer; meta-analysis; miRNAs; polymorphism.
Conflict of interest statement
Figures





Similar articles
-
The association of common functional polymorphisms in mir-146a and mir-196a2 and hepatocellular carcinoma risk: evidence from a meta-analysis.Medicine (Baltimore). 2014 Dec;93(29):e252. doi: 10.1097/MD.0000000000000252. Medicine (Baltimore). 2014. PMID: 25546664 Free PMC article. Review.
-
The association between two common polymorphisms (miR-146a rs2910164 and miR-196a2 rs11614913) and susceptibility to gastric cancer: A meta-analysis.Cancer Biomark. 2015;15(3):235-48. doi: 10.3233/CBM-150470. Cancer Biomark. 2015. PMID: 26406571
-
Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and cancer risk: evidence based on 45,816 subjects.Tumour Biol. 2014 Jul;35(7):6271-82. doi: 10.1007/s13277-014-1822-3. Epub 2014 Mar 15. Tumour Biol. 2014. PMID: 24633889
-
Quantitative assessment of the association between miR-196a2 rs11614913 polymorphism and gastrointestinal cancer risk.Mol Biol Rep. 2013 Jan;40(1):109-16. doi: 10.1007/s11033-012-2039-4. Epub 2012 Nov 17. Mol Biol Rep. 2013. PMID: 23160898
-
rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis.Onco Targets Ther. 2018 Mar 1;11:1121-1139. doi: 10.2147/OTT.S154211. eCollection 2018. Onco Targets Ther. 2018. PMID: 29535537 Free PMC article. Review.
Cited by
-
Functional gene polymorphisms and expression alteration of selected microRNAs and the risk of various gastric lesions in Helicobacter pylori-related gastric diseases.Front Genet. 2023 Jan 12;13:1097543. doi: 10.3389/fgene.2022.1097543. eCollection 2022. Front Genet. 2023. PMID: 36712871 Free PMC article.
-
MAP3K1 rs889312 polymorphism and cancer prognosis: A systematic review and meta-analysis.Cancer Rep (Hoboken). 2023 Jan;6(1):e1773. doi: 10.1002/cnr2.1773. Epub 2022 Dec 22. Cancer Rep (Hoboken). 2023. PMID: 36560873 Free PMC article.
-
The role of miRNAs in Behçet's disease.Front Immunol. 2023 Oct 4;14:1249826. doi: 10.3389/fimmu.2023.1249826. eCollection 2023. Front Immunol. 2023. PMID: 37860009 Free PMC article. Review.
-
Impacts of Mir146a Genotypes on Bladder Cancer Risk in Taiwan.Biomedicines. 2023 May 8;11(5):1396. doi: 10.3390/biomedicines11051396. Biomedicines. 2023. PMID: 37239070 Free PMC article.
References
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics 2021. CA Cancer J Clin. 2021;71(3):7-33. - PubMed
-
- Sung H, Ferlay J, Siegel RL, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. - PubMed
-
- Aziz MA, Jafrin S, Islam MS. Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis. Hum Cell. 2021;34(4):1066-1081. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical